Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Identifying microbial biomarkers of neurodegeneration: a comparative study in Alzheimer's and Parkinson's disease.

Frontiers in microbiomes·2026
Same author

Uncertainty analysis of single-time-point organ dosimetry compared with the multi-time-point method in radioimmunotherapy.

EJNMMI physics·2026
Same author

REMOTE-Neuro: co-produced recommendations to optimise remote neurology.

BMJ neurology open·2026
Same author

Corrigendum to "Lecanemab for treatment of individuals with early Alzheimer's Disease (AD) who are apolipoprotein E ε4 (ApoE ε4) non-carriers or heterozygotes" [The Journal of Prevention of Alzheimer's Disease (2026) 100507].

The journal of prevention of Alzheimer's disease·2026
Same author

Correction: Efficient bone marrow irradiation and low uptake by non-haematological organs with an yttrium-90-anti-CD66 antibody prior to haematopoietic stem cell transplantation.

Bone marrow transplantation·2026
Same author

Lecanemab for treatment of individuals with early Alzheimer's Disease (AD) who are apolipoprotein E ε4 (ApoE ε4) non-carriers or heterozygotes.

The journal of prevention of Alzheimer's disease·2026
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

George Devitt1,2, Sofia Michopoulou1, Angus Prosser1

  • 1University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

拉曼光谱学使用机器学习准确地在脑脊液 (CSF) 中识别阿尔茨海默病 (AD). 这种新的方法显示了改善AD诊断在不同的临床群体的希望.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 生物医学光学 生物医学光学
  • 频谱学是一种光谱学.
  • 机器学习在医学中的应用

背景情况:

  • 临床阿尔茨海默病 (AD) 诊断的准确性因不一致性和患者异质性而有所不同.
  • 拉曼光谱法提供了生物流体的快速,无标签的化学分析.
  • 以前的AD分类研究缺乏临床代表性和统计能力.

研究的目的:

  • 评估拉曼光谱和机器学习在代表性临床队列中对AD诊断的有效性.
  • 评估支持向量机 (SVM) 和卷积神经网络 (CNN) 模型在AD分类中的性能.
  • 识别暗示AD的关键光谱特征,并将它们与已确定的生物标志物相关联.

主要方法:

  • 来自141名患者的脑脊液 (CSF) 样本 (66名AD,75名非AD) 用拉曼光谱分析.
  • 机器学习模型 (SVM,CNN) 在80%的数据上进行了训练和优化,并对20%进行了测试.
  • 用AUROC (接收器操作特征曲线下的面积),灵敏度和特异性来评估分类器的性能.

主要成果:

  • 该SVM模型实现了93%的分类准确度,AUROC为0.92.
  • 在分类器分数和患者ATN生物标志物状态之间观察到强烈的相关性.
  • 主要的光谱特征包括来自蛋白质的芳香氨基酸 (氨酸,氨酸).

结论:

  • 拉曼光谱与ML结合,可以从混合临床队列中准确地识别CSF中的AD.
  • 这种方法正确地将其他神经退行性疾病归类为非AD.
  • 需要在更大的研究中进一步验证,以确认潜在的临床转化对人口水平的准确性.